InsidersTradesSigma
Browse the full directors' dealings record of Interpace Diagnostics Group, Inc., a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €48.5m. The latest transaction was disclosed on 5 February 2016 (Attribution). Among the most active insiders: Glorikian Harry. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
4 of 4 declarations